| BID | 47.63 | ASK | 47.68 | ||
| Open | 47.30 | Previous Close | 47.34 | ||
| Pre-Market | - | After-Market | - | ||
| - - | - -% |
| Target Price | 56.57 | Analyst Rating | — — 0.00 | |
| Potential % | 18.62 | Finscreener Ranking | — - | |
| Insiders Trans % 3/6/12 mo. | -/-/- | Value Ranking | ★+ 44.42 | |
| Insiders Value % 3/6/12 mo. | -/-/- | Growth Ranking | — - | |
| Insiders Shares Cnt. % 3/6/12 mo. | -/-/- | Income Ranking | — - | |
| Market Cap | 2.65B | Earnings Rating | — | |
| Price Range Ratio 52W % | 51.98 | Earnings Date | 7th Jan 2021 |
Today's Price Range 46.1347.89 | 52W Range 28.6865.25 |
Summary:
Neutral
| Technical Indicators: | Neutral |
| Moving Averages: | Buy |
| Performance | |||
|---|---|---|---|
| 1 Week | 1.08% | ||
| 1 Month | 0.95% | ||
| 3 Months | -8.90% | ||
| 6 Months | 14.56% | ||
| 1 Year | 60.03% | ||
| 3 Years | - | ||
| 5 Years | - | ||
| 10 Years | - |
| Mngmt Effectiveness | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
ROE (5Y Avg) | - | |||
ROE last 12 Months | -561.41 | |||
ROA (5Y Avg) | - | |||
ROA last 12 Months | -105.99 | |||
ROC (5Y Avg) | - | |||
ROC last 12 Months | -456.70 | |||
Return on invested Capital Q | -5.71 | |||
Return on invested Capital Y | - | |||
Assets Turnover | 0.40 | |||
Receivables Turnover | 12.30 |
| Valuation | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| -5.80 | ||||
| 7.06 | ||||
| 24.95 | ||||
| - | ||||
| -73.80 | ||||
| -0.83 | ||||
| 7.15 | ||||
| 6.63 | ||||
| 2.32B | ||||
| Forward PE | - | |||
| PEG | - |
| Financial Strength | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 5.90 | ||||
| 6.10 | ||||
| - | ||||
| - | ||||
| -9.60 | ||||
| Leverage Ratio | 2.90 |
| Profitability | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 43.40 | ||||
| -27.90 | ||||
| -22.60 | ||||
| - | ||||
| -41.33 |
| Revenue | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 111.13M | ||||
| 1.90 | ||||
| - | ||||
| - |
| Dividends | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| - | ||||
| - | ||||
| - | ||||
| - | ||||
| Payout ratio | - |
| Earnings History | Estimate | Reported | Surprise % |
|---|---|---|---|
| Q03 2021 | -0.35 | -0.32 | 8.57 |
| Q02 2021 | -0.42 | -0.47 | -11.90 |
| Q01 2021 | - | -1.86 | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| Earnings Per End | Estimate | Revision % | Trend |
|---|---|---|---|
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| Next Report Date | - |
| Estimated EPS Next Report | -0.35 |
| Estimates Count | 7 |
| EPS Growth Next 5 Years % | - |
| Volume Overview | |
|---|---|
| Volume | 312.35K |
| Shares Outstanding | 55.49M |
| Trades Count | 4.64K |
| Dollar Volume | 51.43M |
| Avg. Volume | 986.41K |
| Avg. Weekly Volume | 446.19K |
| Avg. Monthly Volume | 1.02M |
| Avg. Quarterly Volume | 973.69K |
Accolade Inc. (NASDAQ: ACCD) stock closed at 47.69 per share at the end of the most recent trading day (a 0.74% change compared to the prior day closing price) with a volume of 313.30K shares and market capitalization of 2.65B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Healthcare Providers & Services industry, Healthcare sector and employs 1230 people. Accolade Inc. CEO is Rajeev Singh.
The one-year performance of Accolade Inc. stock is 60.03%, while year-to-date (YTD) performance is 9.63%. ACCD stock has a five-year performance of %. Its 52-week range is between 28.68 and 65.25, which gives ACCD stock a 52-week price range ratio of 51.98%
Accolade Inc. currently has a PE ratio of -5.80, a price-to-book (PB) ratio of 7.06, a price-to-sale (PS) ratio of 24.95, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -105.99%, a ROC of -456.70% and a ROE of -561.41%. The company’s profit margin is -41.33%, its EBITDA margin is -22.60%, and its revenue ttm is $111.13 Million , which makes it $1.90 revenue per share.
Of the last four earnings reports from Accolade Inc., there were 1 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.35 for the next earnings report. Accolade Inc.’s next earnings report date is -.
The consensus rating of Wall Street analysts for Accolade Inc. is — (), with a target price of $, which is 0.00% compared to the current price. The earnings rating for Accolade Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Accolade Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Accolade Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 20.38, ATR14 : 3.36, CCI20 : 53.88, Chaikin Money Flow : -0.06, MACD : -1.11, Money Flow Index : 59.63, ROC : 7.24, RSI : 44.65, STOCH (14,3) : 75.03, STOCH RSI : 1.00, UO : 53.55, Williams %R : -24.97), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Accolade Inc. in the last 12-months were:
Accolade Inc.
Accolade Inc offers technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits. it generates revenue through providing personalized health guidance solutions to members.
CEO: Rajeev Singh
Telephone: +1 206 926-8100
Address: 1201 Third Avenue, Seattle 98101, WA, US
Number of employees: 1 230
